JMP Securities Reaffirms Market Outperform Rating for Addus HomeCare (NASDAQ:ADUS)

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “market outperform” rating restated by equities researchers at JMP Securities in a report released on Friday,Benzinga reports. They presently have a $150.00 price objective on the stock. JMP Securities’ price objective suggests a potential upside of 31.82% from the stock’s current price.

A number of other research analysts have also weighed in on ADUS. Wall Street Zen lowered Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Stephens reiterated an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Wednesday, March 12th. Finally, Macquarie restated an “outperform” rating and set a $133.00 target price on shares of Addus HomeCare in a report on Tuesday, June 10th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $142.57.

Addus HomeCare Stock Down 1.2%

Shares of NASDAQ ADUS opened at $113.79 on Friday. The firm has a market cap of $2.09 billion, a price-to-earnings ratio of 25.69, a price-to-earnings-growth ratio of 1.61 and a beta of 0.81. The company’s 50-day simple moving average is $108.91 and its 200-day simple moving average is $111.90. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The firm had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. During the same period last year, the company posted $1.21 EPS. Addus HomeCare’s quarterly revenue was up 20.3% compared to the same quarter last year. Equities analysts predict that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president now directly owns 7,796 shares of the company’s stock, valued at approximately $896,540. The trade was a 20.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 4.60% of the stock is currently owned by insiders.

Institutional Trading of Addus HomeCare

A number of hedge funds and other institutional investors have recently bought and sold shares of ADUS. Natixis raised its position in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after acquiring an additional 132 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after purchasing an additional 214 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Addus HomeCare during the 1st quarter worth approximately $41,000. Parkside Financial Bank & Trust grew its position in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after buying an additional 148 shares during the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in shares of Addus HomeCare in the 4th quarter valued at $77,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.